FUSION PHARMACEUTICALS INC - COM (FUSN)

CUSIP: 36118A100

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
28,219,611
Share change
+550,814
Total reported value
$219,062,395
Price per share
$7.77
Number of holders
28
Value change
+$4,373,695
Number of buys
4
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q1 2022

As of 31 Mar 2022, FUSION PHARMACEUTICALS INC - COM (FUSN) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,219,611 shares. The largest 10 holders included JOHNSON & JOHNSON, FMR LLC, ORBIMED ADVISORS LLC, CANADA PENSION PLAN INVESTMENT BOARD, FEDERATED HERMES, INC., ADAMS STREET PARTNERS LLC, TPG GP A, LLC, Pivotal bioVenture Partners Investment Advisor LLC, PERCEPTIVE ADVISORS LLC, and Rock Springs Capital Management LP. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.